These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16575051)

  • 1. Access to antiretrovirals still too scarce in many countries.
    Zarocostas J
    BMJ; 2006 Apr; 332(7544):748. PubMed ID: 16575051
    [No Abstract]   [Full Text] [Related]  

  • 2. Campaign to expand access to antiretrovirals faces major obstacles.
    Fleck F
    BMJ; 2005 Jan; 330(7485):212. PubMed ID: 15677640
    [No Abstract]   [Full Text] [Related]  

  • 3. Brazil celebrates 10 years of universal access to antiretrovirals.
    Morales K
    BMJ; 2006 Nov; 333(7576):989. PubMed ID: 17095776
    [No Abstract]   [Full Text] [Related]  

  • 4. Allocating antiretrovirals in South Africa: using modeling to determine treatment equity.
    Wilson DP; Blower SM
    PLoS Med; 2005 Jun; 2(6):e155; author reply e186. PubMed ID: 15971938
    [No Abstract]   [Full Text] [Related]  

  • 5. Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
    ; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
    AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationing antiretroviral therapy in Africa--treating too few, too late.
    Ford N; Mills E; Calmy A
    N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO report says AIDS offers healthcare opportunity.
    Fleck F
    BMJ; 2004 Jan; 328(7430):10. PubMed ID: 14703535
    [No Abstract]   [Full Text] [Related]  

  • 9. World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countries.
    Kuritzkes D; Lange J; Zewdie D
    Nat Med; 2003 Nov; 9(11):1343-4. PubMed ID: 14595419
    [No Abstract]   [Full Text] [Related]  

  • 10. Prioritizing antiretrovirals for second-line therapy in resource-limited countries.
    Naidoo K
    AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296
    [No Abstract]   [Full Text] [Related]  

  • 11. Patents versus patients? Antiretroviral therapy in India.
    Havlir DV; Hammer SM
    N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
    [No Abstract]   [Full Text] [Related]  

  • 12. Learning and doing: operational research and access to HIV treatment in Africa.
    Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
    [No Abstract]   [Full Text] [Related]  

  • 13. Pakistan starts HIV treatment programme.
    Yusufzai A
    BMJ; 2006 Jan; 332(7532):10. PubMed ID: 16399725
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinton brokers deal to lower price of antiretrovirals.
    Abimbola S
    BMJ; 2007 May; 334(7602):1026. PubMed ID: 17510129
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO insists it can meet its target for antiretrovirals by 2005.
    Fleck F
    BMJ; 2004 Jul; 329(7458):129. PubMed ID: 15258053
    [No Abstract]   [Full Text] [Related]  

  • 16. [AIDS in 2031, an inevitable catastrophe?].
    Deleuze J
    Rev Prat; 2010 Jan; 60(1):3. PubMed ID: 20222300
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral therapy in HIV.
    Yu A; Berbari E; Temesgen Z
    J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.
    Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 20. Initiating antiretrovirals in a resource-constrained setting: does one size fit all?
    Wanchu A
    MedGenMed; 2005 Aug; 7(3):67. PubMed ID: 16369293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.